Genomics Reporting Implementation Guide, published by HL7 International / Clinical Genomics. This guide is not an authorized publication; it is the continuous build for version 4.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/genomics-reporting/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
identifier: http://example.org/identifiers/genomicstudies
/urn:uuid:1111-1111-1111-1113 (use: temp, )
status: Available
type: Trio Analysis
startDate: 2023-10-01
interpreter: Practitioner Jane Doel
note:
De novo mutation study of the patient. The Prenatal Trio Whole Exome Sequencing (Prenatal Trio WES) test is ordered by a physician and must be accompanied with a consent form and detailed clinical information. In general, the test is used when prenatal imaging detects an anomaly that strongly suggests that there is an underlying genetic etiology. Prenatal Trio WES is often considered only after fetal chromosome microarray analysis has been non-diagnostic.
analysis
genomeBuild: GRCh38
instantiatesUri: https://pubmed.ncbi.nlm.nih.gov/33927380/
title: Parental Sequence Variation Detection Using Next Generation Sequencing
focus:
- Father Denovo (official) (no stated gender), DoB Unknown ( Medical record number: 6789-11111 (use: temp, ))
- Mother Denovo (official) (no stated gender), DoB Unknown ( Medical record number: 0987-11111 (use: temp, ))
date: 2023-10-01
protocolPerformed: Procedure Sequencing of entire coding region of gene (procedure)
input
type: BAM
input
type: BAM
input
type: BAM
Outputs